Searched for
BRECKENRIDGE PHARMACEUTICAL
Stocks in news: JSW Infra, Dixon Technologies, RIL, Natco Pharma, M&MMarkets experienced sharp selling pressure, nearing a key technical support level. Several companies like JSW Infra, Dixon Technologies, RI...- NATCO Pharma launches generic blood cancer treatment medicine in USNATCO Pharma has launched generic Pomalidomide capsules in the US. This drug treats blood and bone marrow cancer. It is a generic version o...
- Natco Pharma, others sued in US for generic cancer drugThe company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (...
- Natco Pharma's partner Breckenridge Pharmaceutical gets FDA nod for prostate cancer treatment drug
- Stocks in the news: RIL, DMart, ZEEL, Federal Bank, NTPC and BSEReliance Industries has incorporated a new subsidiary in the UAE for trading in crude oil, petroleum products and agricultural commodities.
- Natco Pharma's marketing partner gets USFDA nod for anti-cancer drugNatco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivit...
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Natco's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets f...
- Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
- Natco, Onyx settle cancer drug patent litigationThe Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market.
- Alembic Pharma's partner launches drug for depressive disorderAlembic Pharma had received approval of its ANDA of desvenlafaxine succinate extended release tablets of strengths 50 mg and 100 mg in June...
- Natco Pharma gets USFDA nod for Armodafinil tabletsNatco Pharma has received final approval from the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets.
- Natco Pharma's US partner gets FDA nod for wakefulness tabletsBreckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.
- Natco pharma's US partner files Abbreviated New Drug Application for EverolimusThe drug, used to prevent organ rejection after a kidney or liver transplant, generated sales of $43.5 mn for the 12-mth period ending July.
- UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
- Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
- Alembic Pharmaceuticals soars on patent settlement case with NovartisShares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
Load More
